Urologic Health Raises $11 Million to Advance Noninvasive Bladder Diagnostics

May 15, 2026
Urologic Health has secured $11 million in seed funding to advance its catheter-free bladder function monitoring system and prepare for U.S. market entry.

Urologic Health announced in a press release that it has raised $11 million in seed financing to support clinical validation, regulatory approval, and initial commercialization of its noninvasive bladder function monitoring system. The round was led by an undisclosed strategic investor with participation from Edge Medical Ventures, SHD Partners, Longevity Venture Partners, and other healthcare investors.

The company’s niu System captures bladder activity data without using catheters, offering a noninvasive alternative for assessing conditions such as overactive bladder, urinary retention, and incontinence. Early feasibility studies have shown that the system can record clinically meaningful bladder activity for diagnostic use.

Funds from the round will also support product and manufacturing development and the establishment of Urologic Health’s headquarters in Jersey City, New Jersey, as it prepares for U.S. market entry. The niu System remains limited to investigational use and has not yet received FDA clearance.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

05/15
Enlil Adds Eight MedTech Customers in Record First Quarter of 2026
05/15
Psynk AI Partners with Ocean View Psychiatric Hospital to Deploy AI Psychiatric Assistant
05/15
AI Screening for Childhood Blindness Begins in Mongolia
05/15
ELLKAY Names Lucky Singh Chief Technology Officer
05/15
Optura Raises $17.5 Million Series A from Salesforce Ventures and Echo Health Ventures

More from: Funding

05/15
Blackstone Digital Infrastructure Trust Debuts on NYSE After $1.8 Billion IPO
05/15
Blaize Reports Q1 2026 Results and Launches AI Services Platform
05/15
BluSky AI Launches Regulation A Offering to Expand U.S. AI Infrastructure
05/15
METiS TechBio Lists on Hong Kong Stock Exchange, Raising HKD 2.1 Billion
05/15
Amp Raises $1.3 Billion to Build Shared AI Compute Grid

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like